ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

240m COVID vaccine doses at risk of waste in Japan, U.S. and Europe

Logistical hurdles hinder redistribution of shots before shelf life runs out

G-7 and EU inventories of COVID vaccines are projected to exceed 1 billion doses at the end of 2021.   © Reuters

TOKYO/CAIRO -- Advanced nations hold hundreds of millions of excess coronavirus vaccine doses at risk of expiring before they can be given to people in developing countries that have had greater difficulty in sourcing shots.

About 100 million doses purchased by or promised to Group of Seven and European Union members are to expire by year-end, even after taking booster shots into consideration, an analysis by U.K. research firm Airfinity shows. A total of around 240 million will come within two months of expiring, a point at which they become logistically difficult to send to emerging economies.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more